BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29356312)

  • 41. The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.
    Demirbilek S; Akin M; Gürünlüoğlu K; Aydin NE; Emre MH; Taş E; Aksoy RT; Ay S
    Pediatr Surg Int; 2006 Aug; 22(8):655-63. PubMed ID: 16830161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α.
    Zhu L; Wang L; Cao F; Liu P; Bao H; Yan Y; Dong X; Wang D; Wang Z; Gong P
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):195-205. PubMed ID: 29360226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
    Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
    Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats.
    Oztürk H; Oztürk H; Dokucu AI; Otcu S
    Acta Gastroenterol Belg; 2006; 69(2):197-202. PubMed ID: 16929615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic LGR4 aggravates cholestasis-induced liver injury in mice.
    Gao Y; Zhai W; Sun L; Du X; Wang X; Mulholland MW; Yin Y; Zhang W
    Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G460-G472. PubMed ID: 38440827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-κB Signaling Pathway Inhibition in Bile Duct-Ligated Mice.
    Weng Z; Chi Y; Xie J; Liu X; Hu J; Yang F; Li L
    Cell Physiol Biochem; 2018; 49(3):1083-1096. PubMed ID: 30196285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat.
    Abdel-Salam OM; Baiuomy AR; Ameen A; Hassan NS
    Pharmacol Res; 2005 Jan; 51(1):59-67. PubMed ID: 15519536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the Glutathione Peroxidase by Metformin in the Bile-duct Ligation induced Liver Injury: In vivo Combined with Molecular Docking Studies.
    Mansourian M; Sadeghi H; Doustimotlagh AH
    Curr Pharm Des; 2018; 24(27):3256-3263. PubMed ID: 30280660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats.
    Esrefoglu M; Gül M; Emre MH; Polat A; Selimoglu MA
    World J Gastroenterol; 2005 Apr; 11(13):1951-6. PubMed ID: 15800985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
    Gabbia D; Pozzo L; Zigiotto G; Roverso M; Sacchi D; Dalla Pozza A; Carrara M; Bogialli S; Floreani A; Guido M; De Martin S
    PLoS One; 2018; 13(9):e0204336. PubMed ID: 30252871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
    Sommer J; Dorn C; Gäbele E; Bataille F; Freese K; Seitz T; Thasler WE; Büttner R; Weiskirchen R; Bosserhoff A; Hellerbrand C
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats.
    Ayvaz S; Kanter M; Aksu B; Sahin SH; Uzun H; Erboga M; Pul M
    J Surg Res; 2013 Jul; 183(1):146-55. PubMed ID: 23462455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
    Kolouchova G; Brcakova E; Hirsova P; Sispera L; Tomsik P; Cermanova J; Hyspler R; Slanarova M; Fuksa L; Lotkova H; Micuda S
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1544-51. PubMed ID: 21501227
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Bae UJ; Ryu JH; Park BH; Bae EJ
    J Med Food; 2022 Apr; 25(4):435-442. PubMed ID: 35438551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
    Wang L; Wu G; Wu F; Jiang N; Lin Y
    J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
    Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
    Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.